Yield10 Bioscience, Inc. (YTENQ)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jun 3, 2026, 9:30 AM EST
Market Cap73.00 -100.0%
Revenue (ttm)750.00K +190.7%
Net Income-12.70M
EPS-24.93
Shares Out 734.41K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.000001 - 0.0001
Beta-15.07
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc... [Read more]

Sector Materials
Founded 1992
Employees 29
Stock Exchange OTCMKTS
Ticker Symbol YTENQ
Full Company Profile

Financial Performance

In 2023, Yield10 Bioscience's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.

Financial Statements

News

Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Special Meeting Adjourned to Thursday, November 21, 2024  WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience co...

1 year ago - Accesswire

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on October 16, 2024, providing details for shareholder voting and corporate governance matters.

1 year ago - Filings

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on October 2, 2024, providing details for shareholder voting and corporate governance matters.

1 year ago - Filings

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the secon...

1 year ago - GlobeNewsWire

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has si...

2 years ago - GlobeNewsWire

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina

Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutrition Engineered Camelina is intended to enable the land-based production of...

2 years ago - GlobeNewsWire

Yield10 Bioscience Registration statement: Registration Filing

Yield10 Bioscience filed a registration statement on May 28, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., ...

2 years ago - GlobeNewsWire

Yield10 Bioscience Announces First Quarter 2024 Financial Results

-Earns $1 million in milestone payments from Vision Bioenergy Oilseeds -Earns $1 million in milestone payments from Vision Bioenergy Oilseeds

2 years ago - GlobeNewsWire

Yield10 Bioscience Quarterly report: Q1 2024

Yield10 Bioscience has published its Q1 2024 quarterly earnings report on May 15, 2024.

2 years ago - Filings

Yield10 Bioscience Earnings release: Q1 2024

Yield10 Bioscience released its Q1 2024 earnings on May 15, 2024, summarizing the period's financial results.

2 years ago - Filings

Yield10 Bioscience Slides: Q1 2024

Yield10 Bioscience has posted slides in relation to its Q1 2024 quarterly earnings report, which was published on May 15, 2024.

2 years ago - Filings

Yield10 Bioscience Announces Delisting from Nasdaq

WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a fin...

2 years ago - GlobeNewsWire

Yield10 Bioscience Registration statement: Registration Filing

Yield10 Bioscience filed a registration statement on May 7, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings

Yield10 Bioscience Registration statement: Registration Filing

Yield10 Bioscience filed a registration statement on May 3, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings

Yield10 Bioscience Announces 1-for-24 Reverse Stock Split

WOBURN, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that it will effect a 1-for-24 ...

2 years ago - GlobeNewsWire

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on April 29, 2024, providing details for shareholder voting and corporate governance matters.

2 years ago - Filings

Yield10 Bioscience Registration statement: Registration Filing

Yield10 Bioscience filed a registration statement on April 25, 2024, providing details about a securities offering with the SEC.

2 years ago - Filings

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on April 19, 2024, providing details for shareholder voting and corporate governance matters.

2 years ago - Filings

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on April 4, 2024, providing details for shareholder voting and corporate governance matters.

2 years ago - Filings

Yield10 Bioscience Proxy statement: Proxy Filing

Yield10 Bioscience filed a proxy statement on April 2, 2024, providing details for shareholder voting and corporate governance matters.

2 years ago - Filings

Yield10 Bioscience Annual report: Q4 2023

Yield10 Bioscience has published its Q4 2023 annual report on April 1, 2024.

2 years ago - Filings

Yield10 Bioscience Earnings release: Q4 2023

Yield10 Bioscience released its Q4 2023 earnings on April 1, 2024, summarizing the period's financial results.

2 years ago - Filings

Yield10 Bioscience Slides: Q4 2023

Yield10 Bioscience has posted slides in relation to its Q4 2023 quarterly earnings report, which was published on April 1, 2024.

2 years ago - Filings